People with type 2 diabetes were introduced to Metformin (Glucophage) after the FDA approved the drug in 1994 to lower blood sugar levels. Now several studies have observed this drug’s unique and potent effects against cancer. In a forthcoming Article to be published in the October 1, 2009 Edition of Cancer Research, a Journal of the American Association for Cancer Research, researchers report that a combination of Metformin and Doxorubicin (a chemotherapy drug) killed both regular and stem cell cancer.
Researchers claim that these results have potentially broad implications for cancer treatment. The fact is that the use of Metformin alone, in early-stage breast cancer patients, after surgery and chemotherapy for their tumors, appears to be effective in preventing these cancers from recurring. This seems to be more than wishful thinking. Researchers also have found that diabetic patients treated with Metformin were less likely to develop pancreatic cancer compared to those patients who were not taking the drug for control of blood sugar.
Why or how Metformin affects cancer is not yet certain, but one possible answer is that it deprives tumor cells of sugar. Cancer cells need sugar to thrive. Another answer is the
possibility that the drug affects the immune system and helps stave off tumor recurrences. Harvard Medical School along with others has applied for a patent that would cover a combination of Metformin and a low dose of chemotherapy to treat cancer.
Based on these findings, if you have type 2 diabetes and are taking Metformin, you may have unknowingly been blessed. Perhaps now Metformin may soon get a new life as a cancer preventative or cure. Scamraiders provides you with the foregoing important research and findings for informational purposes only. The forgoing is not intended to be medical advice. Please always consult your physician about all of your medical issues.